Ashish Kumar Mishra* and Abhish Dhelariya

Liver Transplant and HPB Surgery, Apollomedics Hospitals, Lucknow, Uttar Pradesh, India

*Corresponding Author: Ashish Kumar Mishra, Liver Transplant and HPB Surgery, Apollomedics Hospitals, Lucknow, Uttar Pradesh, India

Received: October 28, 2023; Published: December 11, 2023

Abstract

Gallbladder Carcinoma (GBC) is the most common and aggressive tumor of the biliary tract [1]. Patients are typically diagnosed during advanced stages, and the mean overall survival is short 5-year survival rate of 20 % as per the Surveillance, Epidemiology, and End Results (SEER) database [2]. Given its sensitivity and sensitivity Positron Emission Tomography-Computed Tomography (PET-CT) is the investigation of choice especially for diagnostic dilemmas and metastatic disease. We report a case in which despite having locally advanced GBC, PET CT failed to detect both local involvement and lymph node metastasis but aggressive approach enabled complete resection of locally advanced GBC.

Keywords: PET-CT; Gallbladder Cancer; Metastasis

References

1. Lazcano-Ponce EC., et al. “Epidemiology and molecular pathology of gallbladder cancer”. CA: A Cancer Journal for Clinicians 51 (2001): 349-364.
2. “Explorer: An interactive website for SEER cancer statistics”. Surveillance Research Program, National Cancer Institute (2023).
3. Mhatre SS., et al. “Place of birth and risk of gallbladder cancer in India”. Indian Journal of Cancer 53 (2016): 304.
4. Dutta U., et al. “Epidemiology of gallbladder cancer in India”. Chinese Clinical Oncology 4 (2019): 33.
5. Pandit N., et al. “Resectability and prognosis of gallbladder cancer: a cross-sectional study of 100 cases from a tertiary care centre of Eastern Nepal”. Annals of Medicine and Surgery (London)5 (2023): 1755-1760.
6. Ramos-Font C., et al. “Ability of FDG-PET/ CT in the detection of gallbladder cancer”. Journal of Surgical Oncology 109 (2014): 218-2
7. Sachan A., et al. “Raised CA19-9 and CEA have prognostic relevance in gallbladder carcinoma”. BMC Cancer1 (2020): 826.
8. Liu F., et al. “Clinical value of preoperative CA19-9 levels in evaluating resectability of gallbladder carcinoma”. ANZ Journal of Surgery 3 (2019): E76-E80.
9. Zhou X. “Meta-analysis of the diagnostic performance of serum carbohydrate antigen 19-9 for the detection of gallbladder cancer”. The International Journal of Biological Markers 1 (2022): 81-89.
10. Lamarca A., et al. “18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) for patients with biliary tract cancer: Systematic review and meta-analysis”. Journal of Hepatology 71 (2019): 115-129.
11. Arslan E., et al. “The Role of 18F-FDG PET/CT in staging of gallbladder carcinomas”. Turkish Journal of Gastroenterology 2 (2020): 105-112.
12. Sacks A., et al. “Value of PET/CT in the management of liver metastases, part 1”. American Journal of Roentgenology 2 (2011): W256-259.
13. Goel S., et al. “18-FDG PET-CT should be included in preoperative staging of gall bladder cancer”. European Journal of Surgical Oncology 9 (2020): 1711-1716.
14. Corvera CU., et al. “18F-fluorodeoxyglucose positron emission tomography influences managment decisions in [patients with biliary cancer”. Journal of the American College of Surgeons 206 (2008): 57-65.

Citation

Citation: Ashish Kumar Mishra and Abhish Dhelariya. “PET-CT is not “Sine-Qua-Non” for Advanced Gallbladder Cancer: A Case Report with Review of Literature".Acta Scientific Gastrointestinal Disorders 7.1 (2024): 13-15.

Copyright

Copyright: © 2024 Ashish Kumar Mishra and Abhish Dhelariya. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.